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Pharmaceutical industries add excipients in therapeutic protein formulations to stabilize monoclonal antibodies 
(mAbs) against surface-induced denaturation and aggregation1. Excipients such as commercially available 
polysorbate (PS) 20 and PS 80 can modulate the interfacial behavior of mAbs in solution due to their 
amphiphilic nature, and thereby enhance long-term stability and storage of therapeutic protein formulations1. 
Commercially available PSs used in protein formulations are extremely heterogeneous and contain complex 
molecular entities which mainly comes from different types of fatty acid esters in the hydrophobic chain1. Recent 
findings in bio-pharmaceutical industries confirm that the structural heterogeneity and manufacturing byproducts 
make them susceptible to degrade via ester-hydrolysis and auto-oxidation at pharmaceutically relevant 
conditions1,2. The possible consequences of such degradation mechanisms are: (1) loss of surfactant 
functionality due to change in the PS structure in both unimer and micelle (2) accumulation of degradants that 
can lead to formation of sub-visible and visible particle in therapeutic formulations2,3,4. These phenomena can 
severely impact the product quality and produce unwanted immune responses1,2,3,4. Furthermore, these 
degradation mechanisms produce different degradation profiles due to preferential degradation and can respond 
differently to the assay techniques typically employed by pharmaceutical industries5. Therefore, we performed a 
design of experiments to determine the micellar morphologies of the individual components of PS 20 and PS 80 
using small angle neutron scattering (SANS) for comparison to SANS experiments on selectively degraded, 
commercial PS solutions with the goal of identifying specific components responsible for the properties of the 
degraded samples. The stability of the components of PS 20 and PS 80 micelles are studied under thermal 
stress, confirming that PS molecules with two hydrophobic tail groups are more prone to morphology changes 
leading to solution instability. To understand the mechanistic pathways of PS degradation, we also investigated 
the solution physiochemical properties and stability of chemically degraded pharmaceutical PS 20 micelles. In 
conclusion, our study demonstrates morphological changes of the PS components as a function of temperature 
which can potentially identify the PS components responsible for degradation under thermal stress. The results 
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